Korsana Biosciences (KRSA) Non Operating Income (2020 - 2025)
Korsana Biosciences' Non Operating Income came in at $30,000 for Q3 2025, down 92.6% from $405,000 a year earlier and down 97.8% from the prior quarter.
Korsana Biosciences (KRSA) Non Operating Income (2020 - 2025) Analysis & Trends
Over the trailing twelve months to Sep 30, 2025, Korsana Biosciences reported Non Operating Income of $1.43 million, up 122.7% year-over-year; for FY2024, it was $571,000, up 59.5% from FY2023.
- Non Operating Income carries a four-year compound annual growth rate of -0.7% (FY2020 to FY2024).
- Going back by year, Non Operating Income was $358,000 in FY2023 (+21.8%), $294,000 in FY2022, -$16,000 in FY2021 and $588,000 in FY2020.
- The five-year range for quarterly Non Operating Income is -$6,000 (Q2 2021) to $1.35 million (Q2 2025).
- Year-over-year, Non Operating Income increased in 1 of the last seven quarters, with growth averaging 1.9%.
- The fastest year-over-year change in Non Operating Income over five years came in Q3 2024 (growth of 278.5%), and the weakest in Q3 2025 (a decline of 92.6%).
- Business Quant data shows KRSA's Non Operating Income at $1.35 million (Q2 2025), $28,000 (Q1 2025) and $28,000 (Q4 2024) in the three quarters before Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Korsana Biosciences | 16.89 Mn | 2.44 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | 28,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | 405,000.00 |
| Jun 30, 2024 | 62,000.00 |
| Mar 31, 2024 | 76,000.00 |
| Dec 31, 2023 | 101,000.00 |
| Sep 30, 2023 | 107,000.00 |
| Jun 30, 2023 | 62,000.00 |
| Mar 31, 2023 | 88,000.00 |
| Dec 31, 2022 | 132,000.00 |
| Sep 30, 2022 | 111,000.00 |
| Jun 30, 2022 | 45,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Sep 30, 2021 | -5,000.00 |
| Jun 30, 2021 | -6,000.00 |
| Mar 31, 2021 | -4,000.00 |
| Dec 31, 2020 | -4,000.00 |
Korsana Biosciences Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=KRSA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "KRSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=KRSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();